IL -12 Expression by Cefodizime As an Immuno-modulator

  • Joo, Seong-Soo (Division of Pharmacology. College of Pharmacy, Chung Ang University) ;
  • Kwon, Hee-Seung (Division of Pharmacology. College of Pharmacy, Chung Ang University) ;
  • Oh, Won-Sik (Division of Pharmacology. College of Pharmacy, Chung Ang University) ;
  • Lee, Do-Ik (Division of Pharmacology. College of Pharmacy, Chung Ang University)
  • Published : 2002.10.01

Abstract

Cefodizime has originally been developed for treating infections as antibiotics. However. according to some of recent studies. cefodizime. a third generation cephalosporin. may potentially have the capability of stimulating chemotactic activity of neutrophils and monocytes as well as the strong immuno-modulator. In this study. we studied to learn about the expressive effect of dentritic cells and macrophage. With this background. We have studied to see if cefodizime can be a potential substance inducing an immunological function in dendritic cells and peritoneal macrophages. IL-12 activates NK cell and macrophage, and shows antiviral effect by excreting INF-${\gamma}$. In vitro. total RNAs were extracted from murine dentritic cell at 4, 8, 12, 24hr after the application of 10, 50, 100${\gamma}g$/ml of cefodizime wighout other stimulators. And we analyzed IL-12 mRNA using RT-PCR method. In conclusion. IL-12 mRNA was increased. and the results suggest that cefodizime activate TH1 cell induction, CTL differentiation as well as accelerating the increase of NK. LAK cell.

Keywords